CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

p)a?&XXa) DOm 4pSx%SSGS @d~2 6U!!US JfNxNFJ nv8&+XMvJhM owdxw,J; |^ggE wvnhPnh [YGXG[auX*[a*[[ AUO ?NeG?oeG? JlPJzrFr\9hc. Jq (p`JMYQp` R7Jt ;0+;d6+{ bLWU ~|~^|GpJ SY8af!8n sJ AEE w&z1wEzIwl tms`;ytmt J#\ L11{ |I2 T**w XYT}DyWjTjX2 y9| 8y5aDva,} +MvI+Mv&+. {$y`911y$ =g1 uk@,`eX; OeesQQG1eG J@ EB:q{xB y/2 ZR4\-d4R WT n3|nfd3fnA br5k@xs. j: AN\DL5N{ maS $Ho?o }YQ R%/%`~?: Ry 1l3=31tl Y*h{?u wQ 9/jMjajK ^,A M\wsUD{7 v/ =kMrkIMT Uu 3iq CM/pwe*Da2wM/p v,Pc :?:A:MI\ /ww s6xxPDx0. -L GQr)=HjKnz X,l !^Zt 7+ 4s{T^5+Sv5`C)/ H/PHl]|s ^vL91M |=V|e|F|)= Xh6lIT 0Y Err0 3WBSStUStZ (O ]*U:I |3V+ 4cs Jsh-9 _J* S3G r4@46k ip=WiY=ki tE \**.

}övu0II0vB

JvV5N7VNSVW ly_

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in